Trademark Search in Canada

RETHINK DEPRESSION DESIGN

View On IC.GC.CA

REGISTERED

on 1 Nov 2021

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby

Serial Number

1895991 filed on 26^th Apr 2018

Registration Number

TMA1112937 registered on 1^st Nov 2021

Registration expiry Date

1^st Nov 2031

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

M5H3S5

RETHINK DEPRESSION DESIGN

Trademark usage description

pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or ac Read More

Vienna Information

1 . 15 . 21

Bubbles, frothy masses -- Note: Including speech bubbles.Bulles, masses mousseuses -- Note: Y compris les bulles de bandes dessinées.

25 . 7 . 20

Surfaces or backgrounds covered with lines or bandsSurfaces ou fonds couverts de lignes ou de bandes

25 . 7 . 22

Surfaces or backgrounds covered with wavy lines or bandsSurfaces ou fonds couverts de lignes ou de bandes ondulées

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 13

Quadrilaterals containing representations of heavenly bodies or natural phenomenaQuadrilatères contenant la représentation de corps célestes ou de phénomènes naturels

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

24 . 17 . 1

Punctuation marksSignes de ponctuation

24 . 17 . 4

Exclamation marks, question marksSignes d'exclamation, signes d'interrogation

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information

Class [005]
Pharmaceuticals and medical preparations and substances and vaccines for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; diagnostic reagents and agents for medical diagnostic use.

Classification kind code

Class [009]
Downloadable electronic publications namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, clinical and medical treatment and prevention of neurological diseases and disorders; educational software for providing instruction in the fields of biotechnology, medical scientific research and development, medical science, clinical testing, medical diagnosis, neurology, pharmaceuticals, health diseases and disorders, medical treatments of diseases and disorders and prevention of diseases and disorders; software, namely, interactive application software for mobile phones, laptops and computers for information in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, treatment and prevention of neurological diseases and disorders; software, namely, application software for mobile phones, laptops and computers for information in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, treatment and prevention of neurological diseases and disorders, and for facilitating communication, namely, allowing patients and healthcare professionals to access and share information in the fields of psychological diagnosis and treatment of psychiatric and neurological disorders and diseases and brain diseases and disorders; downloadable electronic publications, namely, magazines, journals, teaching and educational materials in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, clinical and medical treatment and prevention of neurological diseases and disorders.

Classification kind code

Class [041]
Education services, namely, providing continuing medical education courses in the field of neurology; providing of training, namely, medical training and teaching in the field of neurology; arranging and conducting seminars, conferences, symposiums, training workshops, and courses in the field of neurology; educational and training services in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, treatment and prevention of neurological diseases and disorders, and related to the assessment of cognitive functions; providing educational and training services electronically, on-line, via cable, the Internet, books and magazines in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, treatment and prevention of neurological diseases and disorders, and related to the assessment of cognitive functions; arranging and conducting expert forums in the field of neurology via the internet; providing on-line training programs in the field of neurology; providing non-downloadable on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of medical research and development, medical science, medical clinical studies, tests and trials, medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, treatment and prevention of neurological diseases and disorders, and related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line nondownloadable screening tools.

Classification kind code

Class [042]
Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, medical diseases and prevention of neurological disorders; scientific and technological services, namely, research in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests; clinical research and tests in the field of neurology; diagnostic research and tests in the field of neurology; providing online nondownloadable screening tools, namely, software for assessing cognitive functions.

Classification kind code

Class [044]
Providing, medical, clinical, therapeutic and healthcare services in the nature of neurological assessments; provision of medical, clinical, therapeutic and healthcare information services relating to the prevention and treatment of disorders and diseases in the central nervous system, psychiatric disorders and diseases and neurological disorders and diseases, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; medical consultancy services in the field of psychiatry, psychology and neurology and central nervous system diseases and disorders; advice related to medical and pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in the central nervous system, psychiatric disorders and diseases and neurological disorders and diseases, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency; healthcare and medical services in the field of central nervous system and brain diseases and disorders, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls due to loss of balance, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and alcohol dependency, and pharmaceuticals; providing for medical and medicinal information in the field of medical diagnosis, neurology, pharmaceuticals, health disorders, diseases, treatment and prevention of neurological diseases and disorders; providing on-line medical data and analyses designed to provide patients and clients customized information, namely, medication dosage, diagnosis of neurological conditions, therapeutic issues and medical management of patent medical records.

Classification kind code

Mark Details

Serial Number

1895991

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 21^st Jun 2021	Approved
Submitted for opposition 27 on 21^st Jun 2021	Approval Notice Sent
Submitted for opposition 15 on 3^rd Nov 2020	Correspondence Created
Submitted for opposition 12 on 4^th Feb 2020	Extension of Time
Submitted for opposition 67 on 11^th Sept 2019	Agent Name Changed
Submitted for opposition 22 on 19^th Jul 2019	Search Recorded
Submitted for opposition 20 on 19^th Jul 2019	Examiner's First Report
Submitted for opposition 31 on 30^th Apr 2018	Formalized
Submitted for opposition 1 on 27^th Apr 2018	Created
Submitted for opposition 30 on 26^th Apr 2018	Filed